ArticleToxicology and applied pharmacology2013

Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastoma.

Mariana Puntel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.